Delivery Order SPE2DB22D2007-SPE2DB24FJ2LR
Award Date 5/13/24
Potential Completion Date 5/14/24
Potential Value $3.2K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of the pharmaceutical product Trulicity 0.75 mg/0.5 ml pen 0.5ml. The contract, awarded by the Defense Logistics Agency (DLA), is a Firm Fixed Price Delivery Order with a ceiling value of $3,773.64 and a completion date of May 28, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award to AmerisourceBergen Drug Corp's Corporate Office Division is for the delivery of Trulicity 3 mg/0.5 ml pens, valued at $10,812.40. The contract is a firm-fixed price delivery order issued by the Defense Logistics Agency (DLA), a defense agency, with a completion date of July 2, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00 through December 31, 2025. This single-award IDC serves...
- This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is for the delivery of the pharmaceutical product Trulicity 0.75 mg/0.5 ml pen 0.5 ml. The contract, valued at $2,174.61, was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of May 20, 2024. The contract is a delivery order placed under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA, which has a total potential value of up to...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product Trulicity 0.75 mg/0.5 ml pen 0.5 ml. The contract has a ceiling value of $1,306.26 and is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA valued at up to $999,999,999.00 through December 31, 2025, which serves as the...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, is for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML to the Defense Logistics Agency (DLA) under a Delivery Order valued at $3,308.04. The contract has a firm fixed price and an ultimate completion date of May 21, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product Trulicity 1.5 mg/0.5 ml pen 0.5 ml to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $2,334.75 and a completion date of July 12, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of one of the largest pharmaceutical distributors, is for the delivery of Trulicity 0.75 mg/0.5 ml pens to the Defense Logistics Agency (DLA). The $1,451.40 firm-fixed-price delivery order has a completion date of June 25, 2024 and was awarded on June 24, 2024. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Trulicity 0.75 mg/0.5 ml pens (0.5 ml) to the Defense Logistics Agency (DLA). The $1,306.26 firm-fixed price delivery order has a completion date of May 10, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to provide a...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a $4,013.21 Firm Fixed Price Delivery Order from the Defense Logistics Agency (DLA) for the pharmaceutical product Trulicity 0.75 mg/0.5 ml pen 0.5 ml. The award has an ultimate completion date of July 16, 2024. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of the prescription medication Trulicity 1.5 mg/0.5 ml pen 0.5ml. The contract, awarded by the Defense Logistics Agency (DLA), is a $1,741.68 Firm Fixed Price delivery order with a completion date of July 8, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the primary vehicle for providing a comprehensive range of...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB24FJ2LRDelivery Order
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, valued at $3,238.48, is for the delivery of Trulicity 0.75 mg/0.5 ml pen 0.5 ml to the Defense Logistics Agency (DLA). The contract is a firm-fixed-price delivery order with a completion date of May 14, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This specific award is not designated as a set-aside contract.
Generated 8/12/24, 9:26 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 5/13/24 |